BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38360723)

  • 1. CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a/301a-dependent CDK19 downregulation.
    Jang Y; Kang S; Han HH; Kim BG; Cho NH
    Cell Death Discov; 2024 Feb; 10(1):81. PubMed ID: 38360723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-130a-3p/301a-3p attenuates high glucose-induced MPC5 podocyte dysfunction through suppression of TNF-α signaling.
    Jiang Y; Wang W; Liu ZY; Xie Y; Qian Y; Cai XN
    Exp Ther Med; 2018 Jan; 15(1):1021-1028. PubMed ID: 29434693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue.
    Jiang Y; Shi Y; Lyu T; Liu H; Shen L; Zhou T; Feng W
    Cancer Manag Res; 2021; 13():6585-6597. PubMed ID: 34456588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone Suppresses Palatal Cell Proliferation through miR-130a-3p.
    Yoshioka H; Jun G; Suzuki A; Iwata J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.
    de Lima AB; Silva LM; Gonçales NG; Carvalho MRS; da Silva Filho AL; da Conceição Braga L
    Cancer Microenviron; 2018 Jun; 11(1):85-92. PubMed ID: 29307001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs.
    Kwon JE; Jang Y; Yun BS; Kang S; Kim YH; Kim BG; Cho NH
    Cell Prolif; 2024 May; 57(5):e13582. PubMed ID: 38030594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance.
    Rampioni Vinciguerra GL; Capece M; Distefano R; Nigita G; Vecchione A; Lovat F; Croce CM
    Signal Transduct Target Ther; 2023 Jan; 8(1):37. PubMed ID: 36702817
    [No Abstract]   [Full Text] [Related]  

  • 8. Time-resolved single-cell sequencing identifies multiple waves of mRNA decay during the mitosis-to-G1 phase transition.
    Krenning L; Sonneveld S; Tanenbaum ME
    Elife; 2022 Feb; 11():. PubMed ID: 35103592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.
    Lánczky A; Győrffy B
    J Med Internet Res; 2021 Jul; 23(7):e27633. PubMed ID: 34309564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs as Novel Therapeutics in Cancer.
    Romano G; Acunzo M; Nana-Sinkam P
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a Framework for Better Understanding of Quiescent Cancer Cells.
    Nik Nabil WN; Xi Z; Song Z; Jin L; Zhang XD; Zhou H; De Souza P; Dong Q; Xu H
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807533
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.